Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14836 total
Omega Healthcare Investors has just reported Q3 results and the stock is holding its ground, with shorts trimmed, options defensiveness unwinding, and the analyst debate now focused on how much of the bull case is…
NVIDIA added 2.3% on Tuesday to close at $206.69, a welcome reversal after a bruising week that left the stock down 5.2%. That weekly loss is actually less severe than the peer median of roughly 10%: AMD dropped 13.6%…
NKE enters its November 16 earnings report in an unusual position: short sellers have been quietly reducing exposure while the stock recovers ground, yet the analyst community remains sharply divided on whether the…
Newmont Corporation is now down 7% on the month, the post-earnings selling has not stopped, and the shorts who built positions after the October 22 miss are quietly reducing them. The most notable shift in the data…
Neurocrine Biosciences delivered its biggest single-day gain in recent memory on November 3, jumping 13.4% to $164.85 after Q3 results, leaving a rebuilt short position badly offside. Short interest had climbed…
NOV has extended its post-earnings decline, dropping 10% on the week to $18.49, and the bears who held through the Q3 miss are under no pressure to cover. Short interest has edged fractionally lower since the previous…
The story at MS this week is a widening gap between what the Street thought the quarter would deliver and what it got, leaving analysts clustered around cautious holds while one high-conviction buyer moved in the…
Modine Manufacturing reported fiscal second-quarter results on November 4, and the question now is whether a stock down nearly 30% over the past month has absorbed enough bad news to find a floor. The analyst response…
Micron Technology has shed another 8% over the past week, closing at $855.10 on Tuesday, yet the bearish positioning that might be expected to accompany such a move remains conspicuously absent. The stock is now down…
Microsoft has spent the week doing something its upgraded analyst targets cannot explain: drifting sideways while the options market turns measurably more defensive than at any point in recent months. The sharpest…
McKesson has crossed the $1,000 mark for the first time, trading at $999.62 after a 10.8% gain over the past month, while the short position against it has moved in the opposite direction, falling 15.8% over the same…
McDonald's closed Tuesday at $263.04, down 1% on the day but still up 5.4% on the week, a gain roughly in line with the 5.2% median across its closest restaurant peers and extending a 13.4% recovery over the past…
Martin Marietta Materials is the most shorted name in its immediate peer group right now, with short interest at 5.5% of free float, the highest level in at least a year, even as the stock outran most peers with an 8%…
The Manitowoc Company heads into its Q3 earnings release with a striking split: short sellers spent October adding aggressively, yet the stock still closed the week 5.7% higher at $23.80. The positioning story has…
Louisiana-Pacific enters the post-earnings week with shorts trimming and options turning more constructive, while analysts clash over whether the Siding franchise can carry the stock through another rough OSB…
Lockheed Martin has spent the past week digesting a 26% one-month price surge, with short sellers making no meaningful push against the move and the analyst community still busy raising targets in its wake. Short…
KMT reported earnings on November 4, the same day this note was filed, and the positioning heading into the print was notably tilted toward optimism rather than caution. The clearest signal came from options. The…
JPMorgan Chase is heading into the final stretch of Q4 at $337.98, up just 0.65% on the week, with a valuation that continues to look disconnected from the quality of the underlying business. The analyst community is…
IFF is the least crowded short among its closest specialty-chemicals peers, with 5.7% of its free float sold short, even as the stock shed 1.1% over the past week against a median gain of 3.3% across correlated names…
Intel has shed 35% in a week and nearly half its value over the past month, yet the CEO just spent almost $10 million buying stock in the open market at $64.73. That purchase by Lip-Bu Tan on November 2, filing the day…
